Latest current assets for 4111.TWO: $980M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
The latest current assets for 4111.TWO is $980M as of June 2026. That compares with $840M in the prior-year period — up 16.5% year over year. Investors often review this figure alongside Chi Sheng Pharma & Biotech , Ltd's historical trend and sector peers before judging valuation or financial health.
Over the past year, 4111.TWO's current assets moved from $840M to $980M — a 16.5% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Chi Sheng Pharma & Biotech , Ltd's operating scale or balance-sheet position.
A current assets figure of $980M for 4111.TWO is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.
After noting 4111.TWO's current assets ($980M), review year-over-year change from $840M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.